[{"path":"/safety/recalls-market-withdrawals-safety-alerts/fresenius-kabi-issues-voluntary-nationwide-recall-two-lots-fluorouracil-injection-due-potential","field_change_date_2":"07/02/2019","field_brand_name":"<a href=\"/safety/recalls-market-withdrawals-safety-alerts/fresenius-kabi-issues-voluntary-nationwide-recall-two-lots-fluorouracil-injection-due-potential\">Fresenius Kabi, Novaplus</a>","field_product_description":"Fluorouracil Injection","field_recall_reason_description":"Potential for glass particulate","field_recall_reason":"Potential Foreign Material","field_company_name":"Fresenius Kabi USA, LLC","field_product_type":"Generic Drugs","term_node_tid":"Generic Drugs","field_regulated_product_field":"Drugs","all-terms-rewrite":"Drugs, Generic Drugs","publicationDate":"2019-07-02T04:00:00.000Z","link":"https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/fresenius-kabi-issues-voluntary-nationwide-recall-two-lots-fluorouracil-injection-due-potential","canonicalId":"002b35c704003aa6cb9eb2cb6a5b823b300665634191a834c5c0fc3d675ebc23","title":"Fresenius Kabi Issues Voluntary Nationwide Recall of Two Lots of Fluorouracil Injection Due to the Potential for Glass Particulate","description":"Fresenius Kabi USA, LLC is voluntarily recalling two lots of Fluorouracil Injection, USP 5g/100mL (50mg/mL), 100mL fill in 100mL vials, to the user level due to the potential for glass particulate.","feedName":"fda","feedSource":"fda","categories":[]}]